Patient Guide: Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 25 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT03598608
Status: COMPLETED
Condition: Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 25 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Gilbert, Arizona
  • • Duarte, California
  • • Los Angeles, California
  • • And 22 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) - Join Clinical Trial NCTNCT03598608

How to Join This Clinical Trial - NCTNCT03598608

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell. Current status: COMPLETED.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
COMPLETED
Study Identifier
NCTNCT03598608 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 25 locations. Find a study site near you:

Clinical Research Site

Gilbert, Arizona 85234 - United States

Status: Contact for availability

Clinical Research Site

Duarte, California 91010 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90095 - United States

Status: Contact for availability

Clinical Research Site

Monterey, California 93940 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19111 - United States

Status: Contact for availability

Clinical Research Site

Austin, Texas 78705 - United States

Status: Contact for availability

Clinical Research Site

Concord, New South Wales 2139 - Australia

Status: Contact for availability

Clinical Research Site

Woollongabba, Queensland 4102 - Australia

Status: Contact for availability

And 15 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation